This investigational compound has shown great efficacy in research settings, with clinical trials showing up to 24.2% mean weight loss in obese non-diabetic subjects at higher concentrations over 48 weeks.The peptides development is a reflection of the evolution of research tools targeting metabolic and gastrointestinal pathways
* These statements have not been evaluated by the Food and Drug Administration
Why havent GLP-1 agonists been approved for NASH
Wegovy, on the other hand, mimics the natural hormone GLP-1, which helps regulate appetite by promoting a feeling of fullness and reducing hunger
Compare that to sublingual delivery, which research suggests can achieve bioavailability potentially reaching 40% under optimal conditions
For lunch or dinner, use quinoa as the base for a hearty bowl, adding grilled chicken or tofu and plenty of non-starchy vegetables